CDR404 is a highly potent and specific T-cell engaging bispecific and bivalent antibody designed for the treatment of cancers positive for the tumor-associated…

Select Advanced Solid Tumors

~Estimated

~$10 – $8,750

CDR-Life AGNCT06402201

Phase 1

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

Phase 1 is to find the recommended dose of KSQ-004EX to give to participants with advanced solid tumors. Phase 2 is to learn if KSQ-004EX at the recommended d…

Select Advanced Solid Tumors

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT06598371